lawsuits against astrazeneca regarding its alleged failure to disclose the risks like diabetes of its drug quetiapine seroquel are on the rise apparently , more than cases were filed in delaware state court in april i'm not entirely clear if the latest lawsuits also allege off label marketing , which is apparently becoming something of a calling card for az these days off label marketing has been part of other seroquel legal actions no wonder , as it appears that seroquel is being investigated as a treatment for , well , everything , as i 've pointed out previously , , , , more details here hat tip furious seasons and pharmalot